F. Loberiza

发表

Are lymphoma survivors really at higher risk for unemployment/underemployment?

Patrick Tang, F. Loberiza, 2012, Leukemia & lymphoma.

Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.

K. van Besien, Stephanie J. Lee, S. Giralt, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Scott, M. DeBaun, J. Panepinto, 2005, British journal of haematology.

Temporal and Regional Variations in the Use of Preoperative Radiation Therapy for Rectal Cancer

J. Meza, C. Enke, Chi Lin, 2010, American journal of clinical oncology.

Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels.

H. Miura, D. Gutterman, Y. Liu, 2000, American journal of physiology. Heart and circulatory physiology.

Flow-Induced Dilation of Human Coronary Arterioles

Takashi Saito, H. Miura, M. Miura, 2001 .

Estimating the State-Level Supply of Cancer Care Providers: Preparing to Meet Workforce Needs in the Wake of Health Care Reform.

J. Armitage, J. Vose, J. Stimpson, 2015, Journal of oncology practice.

The Cancer Care Workforce in Nebraska

J. Armitage, J. Vose, J. Stimpson, 2014 .

study International Bone Marrow Transplant Registry (IBMTR) prospective Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and systems: a joint Société Française de Greffe de Moëlle et Thérapie Prospective evaluation of 2 acute graft-versus-host (GVHD) grading

J. Klein, D. Blaise, M. Horowitz, 2013 .

Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study.

J. Klein, D. Blaise, M. Horowitz, 2005, Blood.

Association of Distance from Transplantation Center and Place of Residence on Outcomes after Allogeneic Hematopoietic Cell Transplantation.

B. Sandmaier, F. Appelbaum, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Psychological Correlates of Having Advance Care Planning in Patients with Hematological Malignancies.

Stephanie J. Lee, R. Goldman, R. Matsuyama, 2009 .

Promoting oral cancer examinations to medical primary care providers: a cluster randomized trial.

Alvin G. Wee, C. Pullen, M. Nunn, 2016, Journal of public health dentistry.

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

A. Zander, M. Horowitz, J. Liesveld, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transplant Center Characteristics And Survival After Allogeneic Hematopoietic Cell Transplantation In Adults

Stephanie J. Lee, B. Logan, S. Parsons, 2019, Bone Marrow Transplantation.

Quality of life after chemotherapy or hematopoietic cell transplant in follicular lymphoma: what's next?

F. Loberiza, N. Barber, 2012, Leukemia & lymphoma.

Association of positive family history with survival of patients with lung cancer.

A. Kessinger, A. Ganti, F. Loberiza, 2009, Lung cancer.

transplantation for follicular lymphoma Comparison of autologous and allogeneic hematopoietic stem cell

J. Armitage, J. Vose, M. Horowitz, 2013 .

Utility of prechemotherapy evaluation of left ventricular function for patients with lymphoma.

P. Bierman, J. Vose, M. Bast, 2015, Clinical lymphoma, myeloma & leukemia.

Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B‐cell lymphoma

T. Greiner, Lynette M. Smith, P. Bierman, 2017, Neuropathology : official journal of the Japanese Society of Neuropathology.

The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.

J. Klein, M. Horowitz, C. Anasetti, 2001, Blood.

Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.

J. Armitage, P. Bierman, R. Bociek, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of use of vascular access devices in patients undergoing hematopoietic stem cell transplantation: results of an international survey

C. Freytes, F. Loberiza, J. Toro, 2007, Supportive Care in Cancer.

Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities.

K. van Besien, Stephanie J. Lee, M. Eapen, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of number of follow-up providers with outcomes in survivors of hematologic malignancies

J. Armitage, J. Vose, H. McIlvain, 2010, Leukemia & lymphoma.

Factors affecting bone marrow toxicity following administration of carboplatin and paclitaxel in patients with non-small cell lung cancer.

A. Kessinger, A. Ganti, F. Loberiza, 2010, Anticancer research.

Veno‐occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation

W. Saber, C. Duncan, F. Loberiza, 2021, Pediatric blood & cancer.

Prior Gemtuzumab Ozogamicin Exposure in Adults With Acute Myeloid Leukemia Does Not Increase Hepatic Veno-occlusive Disease Risk After Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis.

W. Saber, V. Ho, F. Loberiza, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Usual and worst symptom severity and interference with function in breast cancer survivors.

M. Hertzog, A. Berger, F. Loberiza, 2012, The journal of supportive oncology.

What is quality in a transplant program?

F. Loberiza, C. Lemaistre, C. LeMaistre, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interplay between spirituality and religiosity on the physical and mental well-being of cancer survivors

M. Dokucu, F. Loberiza, A. Cannon, 2021, Supportive Care in Cancer.

Effect of gender on endothelium-dependent dilation to bradykinin in human adipose microvessels.

H. Miura, D. Gutterman, M. Demeure, 2002, American journal of physiology. Heart and circulatory physiology.

Effect of Gender and Climacteric Status on Endothelium-Derived Vasodilation by Bradykinin in Human Adipose Microvessels

H. Miura, D. Gutterman, M. Demeure, 2002 .

Diabetes Mellitus Impairs Vasodilation to Hypoxia in Human Coronary Arterioles: Reduced Activity of ATP-Sensitive Potassium Channels

A. Nicolosi, Takashi Saito, H. Miura, 2003, Circulation research.

mpact of Donor and Recipient Sex and Parity n Outcomes of HLA-Identical Sibling Allogeneic ematopoietic Stem Cell Transplantation

D. Porter, A. Cnaan, M. Horowitz, 2006 .

Comparison of Characteristics and Outcomes of Trial Participants and Non-participants: Example of Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

W. Wood, M. Aljurf, J. Wingard, 2015 .

Individual physician practice variation in hematopoietic cell transplantation.

R. Soiffer, Stephanie J. Lee, S. Davies, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

J. Fay, M. Horowitz, R. Gale, 2005, Blood.

COMPARISON OF GRAFT-VS-HOST-DISEASE AND SURVIVAL AFTER HLA- IDENTICAL SIBLING BONE MARROW TRANSPLANTATION IN DIFFERENT ETHNIC POPULATIONS Running Head: Graft-vs-host disease in ethnic populations For Submission to BLOOD, Clinical Observations

J. Fay, M. Horowitz, R. Gale, 2004 .

Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease.

Takashi Saito, H. Miura, D. Gutterman, 2005, American journal of physiology. Heart and circulatory physiology.

HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.

N. Young, A. Barrett, J. Maciejewski, 2002, Blood.

Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.

W. Chan, D. Weisenburger, J. Armitage, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I trial of 90Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation

J. Armitage, P. Bierman, R. Bociek, 2007 .

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

J. Vose, M. Horowitz, R. Gale, 2004, Blood.

Splenectomy and second malignancies in patients with Hodgkin lymphoma: is there a causal relationship?

F. Loberiza, Kailash Mosalpuria, 2015, Leukemia & lymphoma.

Is there a place for routine imaging for patients in complete remission from aggressive lymphoma?

J. Armitage, F. Loberiza, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia.

H. Kantarjian, W. Stock, D. DeAngelo, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatment

H. Kantarjian, V. Welch, E. Vandendries, 2019, Cancer medicine.

Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.

J. Armitage, P. Bierman, R. Bociek, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

M. Horowitz, M. Bishop, Carole B. Miller, 2008, Bone Marrow Transplantation.

Impact of body mass index on pulmonary complications in patients with non-Hodgkin lymphoma treated with hematopoietic stem cell transplant

D. Romberger, Sicong Li, Chi Lin, 2015, Leukemia & lymphoma.

Spirituality, patients' worry, and follow-up health-care utilization among cancer survivors.

E. Reed, F. Loberiza, A. Cannon, 2011, The journal of supportive oncology.

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.

M. Horowitz, R. Gale, P. Tiberghien, 2006, Blood.

Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.

Stephanie J. Lee, P. McCarthy, H. Lazarus, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.

Stephanie J. Lee, P. McCarthy, H. Lazarus, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery.

Michael J. Eckrich, Stephanie J. Lee, B. Logan, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase II Study Of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Peripheral T-Cell Lymphoma (PTCL): Preliminary Results From The T- Cell Consortium Trial

J. Vose, Sonali M. Smith, K. Savage, 2013 .

Quality of Life Assessment in Nonmelanoma Cervicofacial Skin Cancer

Timothy L. Smith, M. Neuburg, F. Loberiza, 2003, The Laryngoscope.

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

N. Schmitz, E. Montserrat, J. Klein, 2000, Blood.

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

N. Schmitz, J. Klein, A. Gratwohl, 2006, Blood.

Decreased treatment failure in recipients of HLA‐identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses

R. Gale, P. Tiberghien, O. Ringdén, 2003, British journal of haematology.

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

J. Klein, J. Wagner, J. Kurtzberg, 2007, The Lancet.

Routine screening for psychosocial distress following hematopoietic stem cell transplantation

P. Richardson, D. Fisher, R. Soiffer, 2005, Bone Marrow Transplantation.

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

M. Horowitz, D. Vesole, C. Bredeson, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

F. Claas, R. Gale, O. Ringdén, 2002, Blood.

Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.

P. Hari, R. Kyle, D. Reece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk Factors, Therapy and Survival Outcomes of Small Cell and Large Cell Neuroendocrine Carcinoma of Urinary Bladder

V. Bhatt, Jue Wang, F. Loberiza, 2014, Rare tumors.

Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.

J. Armitage, P. Bierman, R. Bociek, 2015, Clinical lymphoma, myeloma & leukemia.

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

D. Weisenburger, J. Vose, N. Schmitz, 2003, British journal of haematology.

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.

J. Klein, J. Sierra, M. Horowitz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.

Andrea Bacigalupo, Philip McCarthy, E. Shpall, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinicopathologic characteristics and management trends of cutaneous invasive and in situ melanoma in older patients: a retrospective analysis of the National Cancer Data Base

A. Ganti, V. Bhatt, P. Silberstein, 2015, Therapeutic advances in medical oncology.

Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.

J. Klein, P. Layde, M. Horowitz, 2005, Chest.

Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview.

T. Mok, A. Ganti, H. Azim, 2009, Lung cancer.

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.

J. Klein, J. Wagner, M. Horowitz, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ABO blood group barrier in allogeneic bone marrow transplantation revisited.

A. Barrett, M. Horowitz, R. Gale, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

P. Bierman, J. Vose, N. Schmitz, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advance Care Planning Among Hematopoietic Cell Transplant Patients and Bereaved Caregivers

S. Block, A. Back, Stephanie J. Lee, 2014, Bone Marrow Transplantation.

Coping styles, health status and advance care planning in patients with hematologic malignancies

J. Tulsky, S. Block, A. Back, 2011, Leukemia & lymphoma.

Variation in supportive care practices in hematopoietic cell transplantation.

R. Soiffer, M. Bevans, Stephanie J. Lee, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

J. Armitage, P. Bierman, J. Vose, 2005 .

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States.

J. Klein, M. Horowitz, Stephanie J. Lee, 2005, Blood.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

J. Klein, D. Friedman, K. Ballen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.

D. Porter, A. Cnaan, M. Horowitz, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.

Alan M. Miller, J. Armitage, J. Vose, 2003, Blood.

Transplant registries: guiding clinical decisions and improving outcomes.

M. Horowitz, C. Bredeson, F. Loberiza, 2001, Oncology.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Ruta Bajorunaite, Arturo Molina, John Gibson, 2003, Blood.

Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada.

J. Klein, M. Horowitz, Stephanie J. Lee, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT)

J. Armitage, P. Bierman, R. Bociek, 2013, Bone Marrow Transplantation.

Outcome of infants with a diagnosis of hydrops fetalis in the 1990s.

M. Weiss, F. Loberiza, C. A. Wy, 1999, American journal of perinatology.

Time to Insurance Approval in Private and Public Payers Does Not Influence Survival in Patients Who Undergo Hematopoietic Cell Transplantation.

V. Bhatt, Stephanie J. Lee, F. Loberiza, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Erratum to "A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model" [Computer Methods and Programs in Biomedicine 88 (2007) 95-101]

Xu Zhang, Mei-Jie Zhang, John P. Klein, 2008, Comput. Methods Programs Biomed..

A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model

Xu Zhang, Mei-Jie Zhang, John P. Klein, 2007, Comput. Methods Programs Biomed..

Review of antibody-based immunotherapy in the treatment of non-Hodgkin lymphoma and patterns of use.

F. Loberiza, A. Cannon, 2015, Clinical lymphoma, myeloma & leukemia.

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience

T. Greiner, J. Armitage, Lynette M. Smith, 2016, Leukemia & lymphoma.

Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.

D. Weisenburger, J. Armitage, P. Bierman, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Insights on practice variations in the management of lymphoma and leukemia

P. Bierman, F. Loberiza, A. Cannon, 2014, Leukemia & lymphoma.

Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma.

J. Armitage, P. Bierman, R. Bociek, 2013, Clinical lymphoma, myeloma & leukemia.

Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans’ Affairs Central Cancer Registry (VACCR) cohort analysis

A. Ganti, V. Bhatt, P. Silberstein, 2014, Medical Oncology.

Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.

M. Horowitz, J. Weeks, Stephanie J. Lee, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA: A REPORT OF THE INTERNATIONAL BONE MARROW TRANSPLANT REGISTRY Running head: Allogeneic transplants after autologous failure For Submission to BLOOD, Trans

J. Vose, M. Horowitz, R. Gale, 2004 .

Non‐Hodgkin lymphoma of the prostate

P. Bierman, J. Vose, M. Bast, 2011, American journal of hematology.

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

J. Vose, K. van Besien, H. Lazarus, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B ffect of Body Mass Index on Mortality of Patients ith Lymphoma Undergoing Autologous ematopoietic Cell Transplantation

J. Vose, H. Lazarus, F. Loberiza, 2006 .

Optimistic expectations and survival after hematopoietic stem cell transplantation.

J. Weeks, R. Soiffer, Stephanie J. Lee, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know

M. Horowitz, F. Loberiza, J. D. Rizzo, 2003, Bone Marrow Transplantation.

Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation (ASCT) for Hodgkin lymphoma (HL).

P. Bierman, J. Vose, J. Armitage, 2011, Journal of Clinical Oncology.

Late relapse in patients with diffuse large B‐cell lymphoma

D. Weisenburger, J. Armitage, P. Bierman, 2010, British journal of haematology.

Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

W. Chan, J. Armitage, P. Bierman, 2010 .

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymphoma (PTCL): final results from the T‐ cell consortium trial

R. Advani, Sonali M. Smith, K. Savage, 2016, British journal of haematology.

High-Dose Therapy (HDT) with Hematopoietic Stem Cell Transplantation (HSCT) is effective therapy for patients with Non-Hodgkin Lymphoma (NHL) and Central Nervous System (CNS) involvement

J. Armitage, P. Bierman, R. Bociek, 2010 .

Persistent Disparities in Adult Hematopoietic Cell Transplantation

David G. Crockett, F. Loberiza, 2015, Current Hematologic Malignancy Reports.

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Alan M. Miller, J. Armitage, J. Vose, 2008, Biology of Blood and Marrow Transplantation.

Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study.

D. Weisenburger, J. Armitage, P. Bierman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence.

J. Vose, F. Loberiza, M. Devetten, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residence.

J. Klein, Stephanie J. Lee, H. Lazarus, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation

F. Loberiza, S. Lee, Sj Lee, 2006, Bone Marrow Transplantation.

Flow-Induced Dilation of Human Coronary Arterioles: Important Role of Ca2+-Activated K+ Channels

Takashi Saito, H. Miura, M. Miura, 2001, Circulation.

Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.

J. Armitage, P. Bierman, R. Bociek, 2015, Clinical lymphoma, myeloma & leukemia.

Logistical and Methodological Challenges in Conducting a Mental Health Survey of Mount Pinatubo Disaster Victims

R. Woolson, P. Thorne, B. Pfohl, 2000 .

Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.

W. Wood, M. Aljurf, M. Horowitz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictive Ability of Charlson Comorbidity Index on Outcomes From Lung Cancer

A. Kessinger, A. Ganti, F. Loberiza, 2011, American journal of clinical oncology.

F. Loberiza, V. Minhas, K. Neemann, 2015, Leukemia & lymphoma.

Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy

J. Armitage, P. Bierman, R. Bociek, 2015, American journal of clinical oncology.

Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?

D. Weisenburger, J. Vose, M. Bast, 2009, Leukemia & lymphoma.

High-dose therapy/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin lymphoma.

J. Armitage, P. Bierman, R. Bociek, 2011, Clinical lymphoma, myeloma & leukemia.

The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component

D. Weisenburger, J. Armitage, P. Bierman, 2009, British journal of haematology.

Quality-adjusted life years (QALY) for inotuzumab ozogamicin vs standard of care for relapsed/refractory acute lymphoblastic leukemia (R/R ALL).

B. Heeg, F. Loberiza, T. Wilke, 2017 .

Hospitalization for patients in the United States (US) and European Union (EU) treated with inotuzumab ozogamicin (InO) vs standard of care (SOC) for relapsed/refractory acute lymphoblastic leukemia (R/R ALL) in a global phase 3 trial.

V. Welch, E. Vandendries, F. Loberiza, 2017 .

Association between race and survival of patients with non--small-cell lung cancer in the United States veterans affairs population.

A. Kessinger, A. Ganti, P. Silberstein, 2014, Clinical lung cancer.

Radioimmunotherapy with 131-I tositumomab enhanced survival in good prognosis relapsed and high-risk diffuse large B-cell lymphoma (DLBCL) patients receiving high-dose chemotherapy and autologous stem cell transplantation

J. Armitage, P. Bierman, J. Vose, 2007 .

Effect of Surgical Intervention on Survival of Patients With Clinical N2 Non–Small Cell Lung Cancer: A Veterans’ Affairs Central Cancer Registry (VACCR) Database Analysis

A. Kessinger, I. Aldoss, A. Ganti, 2016, American journal of clinical oncology.

The Impact of Obesity on Stem Cell Transplant

F. Loberiza, W. Navarro, 2012 .

Mantle cell lymphoma (MCL): Induction therapy with HyperCVAD/High-dose methotrexate and cytarabine (M-C) (±rituximab) improves results of autologous stem cell transplant in first remission.

P. Bierman, J. Vose, J. Armitage, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differences in characteristics of United States hematopoietic stem cell transplant (HSCT) centers by proportion of ethnic minorities.

M. Horowitz, M. Eapen, F. Loberiza, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?

D. Weisenburger, J. Armitage, P. Bierman, 2013, Clinical lymphoma, myeloma & leukemia.

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.

J. Armitage, J. Vose, M. Horowitz, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation.

J. Armitage, P. Bierman, R. Bociek, 2007, Leukemia & lymphoma.

The effect of prostate volume on the yield of needle biopsy.

M. Brawer, F. Loberiza, J. Letran, 1998, The Journal of urology.

Cytogenetic abnormalities and clinical correlations in peripheral T‐cell lymphoma

D. Weisenburger, J. Armitage, R. Gascoyne, 2008, British journal of haematology.

Obesity and lymphoma therapy: not a bad combination after all

F. Loberiza, W. Navarro, 2010, Leukemia & lymphoma.